Curative Biotechnology, Inc.
CUBT
$0.0118
$0.00087.27%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 622.30K | 407.70K | 747.60K | 373.80K | 738.40K |
| Depreciation & Amortization | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.08M | 963.40K | 1.29M | 934.00K | 866.30K |
| Operating Income | -1.08M | -963.40K | -1.29M | -934.00K | -866.30K |
| Income Before Tax | -1.42M | -1.29M | -1.40M | -935.90K | -1.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.42M | -1.29M | -1.40M | -935.90K | -1.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.42M | -1.29M | -1.40M | -935.90K | -1.02M |
| EBIT | -1.08M | -963.40K | -1.29M | -934.00K | -866.30K |
| EBITDA | -1.08M | -961.40K | -1.29M | -933.90K | -864.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.03 | 0.00 |
| Normalized Basic EPS | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.03 | 0.00 |
| Normalized Diluted EPS | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | -- | 571.65M | 571.50M | 566.62M | 541.06M |
| Average Diluted Shares Outstanding | 571.65M | 571.65M | 571.50M | 566.62M | 541.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
